There is a shortage of the antidepressant Prozac in Russian pharmacies – Kommersant
[ad_1]
Russian pharmacies are faced with a shortage of the drug Prozac, used to treat depression, reported RBC. As the publication was told in four Moscow pharmacies of the Stolichki, Zdorov.ru, Eapteka, and Dialog chains, the medicine is not on the shelves or in the warehouse, the last delivery was in June and the timing of the next one is unknown.
Prozac is a drug from the pharmaceutical company Elli Lilly, developed in the 1970s to treat depression, obsessive-compulsive disorder, and bulimia nervosa. Prozac appeared in Russia in 1991.
According to RBC’s source in the federal pharmacy chain, pharmacies have been selling remnants of Prozac “for a long time”; suppliers do not have it. This information was confirmed by the Ministry of Health.
As of September 15, Prozac was available in four of the nearly 2.4 thousand Moscow pharmacies connected to the Megapteka service. In St. Petersburg it is available in two out of 1.3 thousand pharmacies, in Voronezh – in five out of 346. In some regions (Novosibirsk and Kazan) the medicine is not available in pharmacies.
Most of the sales, according to DSM Group, are made up of Prozac analogues: in the seven months of 2022, 1.2 million packages were sold, while 77.4 thousand packages of the original medicine were sold. Representative of the Russian division of the Prozac manufacturer Swixx Biopharma reported that supplies are continuing and there are no plans to stop them.
[ad_2]
Source link
